The pharmaceutical industry spends billions of dollars each year on research and development. Rather than capitalize these R&D expenditures as intangible assets, companies are required to charge them to expense in the year incurred. Perform a key word search of pharmaceutical companies using the search engine of your choice. Select $2$ of these companies and obtain their $10$K report by using the SECs EDGAR system or going directly to the websites of the company you choose. For each company selected, determine:Total R&D expense for the most current yearTotal R&D expense as a percentage of total operating costs and expensesTotal R&D expense as a percentage of net salesThe percentage by which operating income would have increased had the entire R&D expenditure been recorded as an intangible asset instead of being charged to expense.Using information from the $10-$K reports, summarize briefly the kinds of drugs being researched and developed by each of these companies. To a potential investor, which company appears to be the most innovative and promising? Please explain.